Matrix metalloproteinase (MMP)-19 and MMP-20 (enamelysin) are two recently discovered members of the MMP family. These enzymes are involved in the degradation of the various components of the extracellular matrix (ECM) during development, haemostasis and pathological conditions. Whereas MMP-19 mRNA is found widely expressed in body tissues, including the synovium of normal and rheumatoid arthritic patients, MMP-20 expression is restricted to the enamel organ. In this study we investigated the ability of MMP-19 and MMP-20 to cleave two of the macromolecules characterising the cartilage ECM, namely aggrecan and the cartilage oligomeric matrix protein (COMP). Both MMPs hydrolysed aggrecan efficiently at the well-described MMP cleavage site between residues Asn341 and Phe342, as shown by Western blotting using neo-epitope antibodies. Furthermore, the two enzymes cleaved COMP in a distinctive manner, generating a major proteolytic product of 60 kDa. Our results suggest that MMP-19 may participate in the degradation of aggrecan and COMP in arthritic disease, whereas MMP-20, due to its unique expression pattern, may primarily be involved in the turnover of these molecules during tooth development. Copyright (C) 2000 Federation of European Biochemical Societies.

Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP) / Stracke, Jan O; Fosang, Amanda J.; Last, Karena; Mercuri, Francesca A.; Pendás, Alberto M.; Llano, Elena; Perris, Roberto; Di Cesare, Paul E.; Murphy, Gillian; Knäuper, Vera. - In: FEBS LETTERS. - ISSN 0014-5793. - 478:1-2(2000), pp. 52-56. [10.1016/S0014-5793(00)01819-6]

Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP)

PERRIS, Roberto;
2000

Abstract

Matrix metalloproteinase (MMP)-19 and MMP-20 (enamelysin) are two recently discovered members of the MMP family. These enzymes are involved in the degradation of the various components of the extracellular matrix (ECM) during development, haemostasis and pathological conditions. Whereas MMP-19 mRNA is found widely expressed in body tissues, including the synovium of normal and rheumatoid arthritic patients, MMP-20 expression is restricted to the enamel organ. In this study we investigated the ability of MMP-19 and MMP-20 to cleave two of the macromolecules characterising the cartilage ECM, namely aggrecan and the cartilage oligomeric matrix protein (COMP). Both MMPs hydrolysed aggrecan efficiently at the well-described MMP cleavage site between residues Asn341 and Phe342, as shown by Western blotting using neo-epitope antibodies. Furthermore, the two enzymes cleaved COMP in a distinctive manner, generating a major proteolytic product of 60 kDa. Our results suggest that MMP-19 may participate in the degradation of aggrecan and COMP in arthritic disease, whereas MMP-20, due to its unique expression pattern, may primarily be involved in the turnover of these molecules during tooth development. Copyright (C) 2000 Federation of European Biochemical Societies.
Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP) / Stracke, Jan O; Fosang, Amanda J.; Last, Karena; Mercuri, Francesca A.; Pendás, Alberto M.; Llano, Elena; Perris, Roberto; Di Cesare, Paul E.; Murphy, Gillian; Knäuper, Vera. - In: FEBS LETTERS. - ISSN 0014-5793. - 478:1-2(2000), pp. 52-56. [10.1016/S0014-5793(00)01819-6]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11381/2813166
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 106
  • ???jsp.display-item.citation.isi??? 93
social impact